Adaptimmune Therapeutics ROI - Return on Investment 2015-2025 | ADAP
Adaptimmune Therapeutics roi - return on investment from 2015 to 2025. Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.